ArticleAnalytical and bioanalytical chemistry2025
Bimetallic-doped carbon quantum dots with enhanced photoluminescence and peroxidase-mimicking activity for dual-mode colorimetric and ratiometric fluorescence assay of alendronate.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preparation of doped Mn, N-CDs and their application in the detection of ampicillin.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Carbon quantum dots (CQDs) are powerful signal transducers in dual-mode assays while still being challenged by their poor peroxidase-mimicking activity and photoluminescence property. Herein, bimetallic copper-iron-doped CQDs (CuFe-CQDs) as a multifunctional nanozyme were proposed for dual-mode colorimetric and ratiometric fluorescence assays of alendronate sodium (ALDS). Notably, CuFe-CQDs were identified to show enhanced and tunable photoluminescence and peroxidase-mimicking activities with bimetallic doping, ascribed to the boosting activation ability of H
Indexed as
Identifiers
40198343What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.